Loading...
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MTEM’s FA Score shows that 0 FA rating(s) are green while.
MTEM (@Biotechnology) experienced а +24.44% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.
MTEM is expected to report earnings on Nov 13, 2023.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
MTEM | ||
---|---|---|
OUTLOOK RATING 1..100 | 51 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 48 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 95 | |
P/E GROWTH RATING 1..100 | 54 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SBIO | |
---|---|
RSI ODDS (%) | 1 day ago77% |
Stochastic ODDS (%) | 1 day ago90% |
Momentum ODDS (%) | 1 day ago90% |
MACD ODDS (%) | 1 day ago90% |
TrendWeek ODDS (%) | 1 day ago87% |
TrendMonth ODDS (%) | 1 day ago90% |
Advances ODDS (%) | 1 day ago89% |
Declines ODDS (%) | 5 days ago90% |
BollingerBands ODDS (%) | 1 day ago74% |
Aroon ODDS (%) | 1 day ago87% |
A.I.dvisor indicates that over the last year, MTEM has been loosely correlated with GOSS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MTEM jumps, then GOSS could also see price increases.
Ticker / NAME | Correlation To MTEM | 1D Price Change % | ||
---|---|---|---|---|
MTEM | 100% | -5.08% | ||
GOSS - MTEM | 39% Loosely correlated | +0.43% | ||
AVRO - MTEM | 39% Loosely correlated | +2.38% | ||
AXON - MTEM | 36% Loosely correlated | -0.98% | ||
CYTK - MTEM | 34% Loosely correlated | -1.82% | ||
EIGR - MTEM | 33% Poorly correlated | +0.50% | ||
More |
A.I.dvisor indicates that over the last year, SBIO has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if SBIO jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To SBIO | 1D Price Change % | ||
---|---|---|---|---|
SBIO | 100% | +0.42% | ||
NTLA - SBIO | 69% Closely correlated | +1.67% | ||
DNLI - SBIO | 67% Closely correlated | -1.30% | ||
RARE - SBIO | 63% Loosely correlated | -0.28% | ||
PCVX - SBIO | 62% Loosely correlated | -0.39% | ||
XNCR - SBIO | 60% Loosely correlated | -1.43% | ||
More |